Literature DB >> 7299081

Spontaneous hyperplastic and neoplastic lesions of the uterus in mice.

M D Reuber, G Vlahakis, W E Heston.   

Abstract

A histologic study was done on the spontaneously occurring hyperplastic and neoplastic lesions of the uterus, cervix, and vagina taken from a variety of inbred, hybrid, and backcross female mice. The most commonly observed neoplasm of the endometrium was stromal cell sarcoma, followed by adenocarcinoma, which occurred approximately half as frequently. Hyperplasia was the most commonly observed endometrial lesion occurring either as glandular, stromal, or both and was often cystic with the formation of polyps. Among the benign and malignant lesions other than endometrial, leiomyomas, hemangioendotheliomas and leiomyosarcomas were the most commonly encountered. Lesions in the mucosal cervix and vagina were comparatively rare and were observed in only a few animals. Females with hyperplastic and neoplastic lesions of the uterus, cervix, and vagina in this survey represented a small fraction of the large number of animals necropsied, emphasizing the relative infrequency of these spontaneous lesions in mice.

Entities:  

Mesh:

Year:  1981        PMID: 7299081     DOI: 10.1093/geronj/36.6.663

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  3 in total

1.  High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.

Authors:  Yali Zhai; Rong Wu; Rork Kuick; Michael S Sessine; Stephanie Schulman; Megan Green; Eric R Fearon; Kathleen R Cho
Journal:  J Pathol       Date:  2017-07-25       Impact factor: 7.996

2.  Endometrial polyps in 2 African pygmy hedgehogs.

Authors:  Irene D Phillips; Jacqueline J Taylor; Andrew L Allen
Journal:  Can Vet J       Date:  2005-06       Impact factor: 1.008

3.  Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.

Authors:  G V Walls; M Stevenson; K E Lines; P J Newey; A A C Reed; M R Bowl; J Jeyabalan; B Harding; K J Bradley; S Manek; J Chen; P Wang; B O Williams; B T Teh; R V Thakker
Journal:  Oncogene       Date:  2017-03-13       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.